Počet záznamov: 1  

Induction of drug resistance in embryonal rhabdomyosarcoma treated with conventional chemotherapy is associated with HLA class I increase

  1. SYSr040570
    LBL
      
    ^^^^^naa^^22^^^^^^^^450^
    005
      
    20130619105503.7
    100
      
    $a 20070222a2006 m y0sloc0103 ba
    101
    0-
    $a eng $d eng
    102
      
    $a SK
    200
    1-
    $a Induction of drug resistance in embryonal rhabdomyosarcoma treated with conventional chemotherapy is associated with HLA class I increase $f J. Prados ... [et al.]
    215
      
    $c obr., tab.
    320
      
    $a Res. angl.
    320
      
    $a Bibliogr. odkazy
    463
    -1
    $1 001 sllk_un_cat*sg000148_2006_006_003 $1 011 $a 0028-2685 $1 200 1 $a Neoplasma $e journal of experimental and clinical oncology $f Cancer Research Institute of the Slovak Academy of Sciences $v Vol. 53, no. 3 (2006), s. 226-231 $1 210 $a Bratislava $c VEDA, vydavateľstvo Slovenskej akadémie vied
    541
    1-
    $a Indukcia liekovej rezistencie pri embryonálnom rabdomyosarkóme liečenom konvenčnou chemoterapiou je spojená so zvýšením HLA I. triedy $z slo
    606
    1-
    $a rabdomyosarkóm embryonálny $x farmakoterapia $x genetika $2 mesh $3 sllk_un_auth*d018233 $9 .
    606
    1-
    $3 sllk_un_auth*d018432 $a rezistencia lieková mnohopočetná $x genetika $9 . $2 mesh
    606
    1-
    $3 sllk_un_auth*d015395 $a antigény histokompatibilné I. triedy $x analýza $9 . $2 mesh
    606
    2-
    $3 sllk_un_auth*d018435 $a ATP-viažuci kazetový transportér, podrodina B $9 . $2 mesh
    606
    2-
    $a gény MDR $2 mesh $3 sllk_un_auth*d019450 $9 .
    606
    2-
    $a imunohistochémia $2 mesh $3 sllk_un_auth*d007150 $9 .
    606
    2-
    $3 sllk_un_auth*d000970 $a antineoplastiká $9 . $2 mesh
    610
    2-
    $a chemoterapia
    610
    2-
    $a HLA antigény
    675
      
    $a 616-006.2.36-085:615.277 $v 2. $z slo
    701
    -1
    $a Prados $b J. $3 sllk_un_auth*p0030346 $4 070 $p Biopathology and Medicine Regenerative Institute, University of Granada, Spain
    701
    -1
    $a Melguizo $b C. $3 sllk_un_auth*p0030345 $4 070 $p Biopathology and Medicine Regenerative Institute, University of Granada, Spain
    701
    -1
    $a Fernández $b J. E. $3 sllk_un_auth*p0047116 $4 070 $p Biopathology and Medicine Regenerative Institute, University of Granada, Spain
    701
    -1
    $a Carrillo $b E. $3 sllk_un_auth*p0030349 $4 070 $p Biopathology and Medicine Regenerative Institute, University of Granada, Spain
    701
    -1
    $a Marchal $b J.A. $3 sllk_un_auth*p0030347 $4 070 $p Biopathology and Medicine Regenerative Institute, University of Granada, Spain
    701
    -1
    $a Boulaiz $b H. $3 sllk_un_auth*p0030350 $4 070 $p Biopathology and Medicine Regenerative Institute, University of Granada, Spain
    701
    -1
    $a Martínez $b A. $3 sllk_un_auth*p0047117 $4 070 $p Biopathology and Medicine Regenerative Institute, University of Granada, Spain
    701
    -1
    $a Rodriguez-Serrano $3 sllk_un_auth*p0047118 $4 070 $p Biopathology and Medicine Regenerative Institute, University of Granada, Spain
    701
    -1
    $a Aránega $b A. $3 sllk_un_auth*p0030636 $4 070 $p Biopathology and Medicine Regenerative Institute, University of Granada, Spain
    801
    -0
    $a SK $b BA006 $c 20070222 $g AACR2
Počet záznamov: 1  

  Tieto stránky využívajú súbory cookies, ktoré uľahčujú ich prezeranie. Ďalšie informácie o tom ako používame cookies.